ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Research Reagent/Fmoc-Asn(Trt)-Thr(Psime,Mepro)-OH
C45H43N3O7
737.8 g/mol
Research Reagent

Fmoc-Asn(Trt)-Thr(Psime,Mepro)-OH

CAS957780-59-5
Category
Research Reagent
Compound Class
Peptide
Primary Use
Research Compound

This compound is a research reagent with a complex polycyclic structure, incorporating multiple aromatic rings and amide functional groups. It is commonly supplied for laboratory use and chemical research.

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Fmoc-Asn(Trt)-Thr(Psime,Mepro)-OH?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

StrongStructure SimilarSimilarity 0.86

Fmoc-Gln(Trt)-Thr(Psi(Me,Me)pro)-OH

CAS1572725-72-4

research compound

SimilarStructure SimilarSimilarity 0.75

Fmoc-Asp(Otbu)-Thr(Psime,Mepro)-OH

CAS920519-32-0

pharmaceutical intermediate

SimilarStructure SimilarSimilarity 0.73

FMOC-ASN(TRT)-SER(PSIME,MEPRO)-OH

CAS920519-33-1

research compound

ReferenceSame Category

5-Bromo-6-methyl-1H-pyrrolo[2,3-b]pyridine

CAS958358-00-4

research compound

ReferenceSame Category

(2-Bromo-3-fluorophenyl)acetic acid

CAS958454-33-6

research compound

ReferenceSame Category

N-(4-Chlorophenyl)-1-methyl-1H-imidazole-4-carboximidamide

CAS959604-71-8

research compound

ReferenceSame Category

6-Methyl-2-(4-methylphenyl)-imidazo[1,2-a]pyridine-d6

CAS959605-52-8

research compound

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

(4S,5R)-3-[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-oxo-4-(tritylamino)butanoyl]-2,2,5-trimethyl-1,3-oxazolidine-4-carboxylic acid

InChIKey

ANJHPIXXMBAZHL-CRSWUFPKSA-N

SMILES

C[C@@H]1[C@H](N(C(O1)(C)C)C(=O)[C@H](CC(=O)NC(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)NC(=O)OCC5C6=CC=CC=C6C7=CC=CC=C57)C(=O)O

Synonyms (10)

—

Sourcing Fmoc-Asn(Trt)-Thr(Psime,Mepro)-OH?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→